The importance of cardiovascular disease for mortality in patients with COPD: A prognostic cohort study

Family Practice

Volumn 28, Issue 5, 2011, Pages 474-481

  Zhang, Jing ^a,b   Rutten, Frans H ^b   Cramer, Maarten J ^b   Lammers, Jan W ^b   Zuithoff, Nicolaas P ^b   Hoes, Arno W ^b  

^a NANTONG UNIVERSITY   (China)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cardiovascular disease; COPD; Prediction; Prognosis

Indexed keywords

C REACTIVE PROTEIN;

AGED; AIRWAY OBSTRUCTION; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; COMORBIDITY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORTALITY; PROGNOSIS; QUANTITATIVE ANALYSIS; SPIROMETRY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; C-REACTIVE PROTEIN; CAUSE OF DEATH; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NETHERLANDS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX; SPIROMETRY; VITAL CAPACITY;

EID: 80052930522     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmr024     Document Type: Article

References (32)

1. Wise RA. The value of forced expiratory volume in 1 second decline in the assessment of chronic obstructive pulmonary disease progression. Am J Med 2006; 119: S4-11.
2. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
3. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: GlobalBurden of Disease Study. Lancet 1997; 349: 1269-76.
4. Incalzi RA, Fuso L, De Rosa M et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-800.
5. Briggs A, Spencer M, WangHet al. Development and validation of a prognostic index for health outcomes in chronic obstructive pulmonary disease. Arch Intern Med 2008; 168: 71-9.
6. Soler-Cataluna JJ, Martinez-Garcia MA, Sanchez PR et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-31.
7. Hiraga T, Maekura R, Okuda Y et al. Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing. Clin Physiol Funct Imaging 2003; 23: 324-31.
8. Celli BR, Cote CG, Marin JM et al. The body-mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-12.
9. de Torres JP, Pinto-Plata V, Casanova C et al. C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008; 133: 1336-43.
10. Man SF, Connett JE, Anthonisen NR et al. C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006; 61: 849-53.
11. Casanova C, Cote C, de Torres JP et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 591-7.
12. Puhan MA, Garcia-Aymerich J, Frey M et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updatedBODE index and the ADOindex. Lancet 2009; 374: 704-11.
13. Yohannes AM, Baldwin RC, Connolly MJ. Predictors of 1-year mortality in patients discharged from hospital following acute7 exacerbation of chronic obstructive pulmonary disease. Age Ageing 2005; 34: 491-6.
14. Goel A, Pinckney RG, Littenberg B. APACHE II predicts longterm survival in COPD patients admitted to a general medical ward. J Gen Intern Med 2003; 18: 824-30.
15. Curkendall SM, DeLuise C, Jones JK et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
16. Meulepas MA, Jacobs JE, Lucas AE et al. The feasibility of a primary care model for the management of COPD. Prim Care Respir J 2006; 15: 337-41.
17. Starfield B, Lemke KW, Bernhardt T et al. Comorbidity: implications for the importance of primary care in case management. Ann Fam Med 2003; 1: 8-14.
18. Rutten FH, Moons KGM, Cramer MJM et al. Recognising heart failure in elderly patients with stable chronic obstructive pulmonary disease in primary care: cross sectional diagnostic study. BMJ 2005; 331: 1379.
19. Rutten FH, Cramer M-JM, Grobbee DE et al. Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 2005; 26: 1887-94.
20. Rose GA, Blackburn H. Cardiovascular Survey Methods, 2nd edn. Geneva, Switzerland: World Health Organisation, 1982(Monograph series 56).
21. van der Lei J, Duisterhout JS, Westerhof HP et al. The introduction of computer-based patient records in the Netherlands. Ann Intern Med 1993; 119: 1036-41.
22. Tantucci C, Donati P, Nicosia F et al. Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease. Respir Med 2008; 102: 613-9.
23. Antonelli-Incalzi R, Corsonello A, Pedone C et al. Drawing impairment predicts mortality in severe COPD. Chest 2006; 130: 1687-94.
24. Machado MCL, Krishnan JA, Buist SA et al. Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 524-9.
25. Ringbaek TJ, Viskum K, Lange P. BMI and oral glucocorticoids as predictors of prognosis in COPD patients on long term oxygen therapy. Chron Respir Dis 2004; 1: 71-8.
26. Steyerberg EW, Eijkemans MJC, Habbema JD. Stepwise selection in small data sets: a simulation study of bias in logistic regression analysis. J Clin Epidemiol 1999; 52: 935-42.
27. Vergouwe Y, Steyerberg EW, Eijkemans MJ, Habbema JD. Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol 2002; 20: 96-107.
28. Harrell FE Jr., Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87.
29. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnoea. Chest 1988; 93: 580-6.
30. Quanjer PH, Tammeling GJ, Cotes JE et al. Lung volumes and forced ventilatory flows. Report working party standardization of lung function tests, European community for steel and coal. Official statement of the European respiratory society. Eur Respir J Suppl 1993; 16: 5-40.
31. Tantucci C, Pinelli V, Cossi S et al. The Sara Study Group. Reference values and repeatability of inspiratory capacity for men and women aged 65-85. Resp Med 2006; 100: 871-7.
32. Fabbri LM, Luppi F, Beghe B, Rabe KF. Complex chronic comorbidities of COPD. Eur Respir J 2008; 31: 204-12.